The metabolism of lysophosphatidylcholine was studied in cultured rat hepatocytes deficient in choline and methionine. Even though the cells were defective in phosphatidylcholine biosynthesis, the albuminstimulated release of lysophosphatidylcholine (1.9 nmol/h per mg of cellular protein) was similar to that in hepatocytes supplemented with choline. Albumin also stimulated (1.4-fold) the release of phosphatidylcholine from the deficient cells. The extra phosphatidylcholine and lysophosphatidylcholine in the medium were largely recovered in the albumin fraction (density > 1.18 g/ml), suggesting that albumin released these lipids from hepatocytes because of binding to this protein. The secretion of glycerophosphocholine was decreased by about 400 by the addition of albumin. When choline-deficient hepatocytes were supplemented with lysophosphatidylcholine, it was transported into the cells and mainly acylated to form phosphatidylcholine, which increased in mass by 30-35 % in the first 4 h of incubation. Lysophosphatidylcholine was shown to be as effective as choline in restoring the secretion of very-low-density lipoproteins to normal amounts, as judged by the secretion of triacylglycerol, phosphatidylcholine and the apolipoproteins associated with very-low-density lipoproteins. Thus phosphatidylcholine synthesis via reacylation of lysophosphatidylcholine, via the CDP-choline pathway or via methylation of phosphatidylethanolamine, will satisfy the requirements for secretion of very-low-density lipoprotein from hepatocytes.
INTRODUCTION
Lysophosphatidylcholine constitutes less than 2 of the total phospholipids in the membranes of rat liver and most other tissues (White, 1973; Ansell & Spanner, 1982a) . The level of this lysophosphatide must be strictly controlled, since it has cytolytic and membraneperturbing properties (Weltzien, 1979) . In rat liver, lysophosphatidylcholine is generated by the deacylation of phosphatidycholine by the action of phospholipases A1 and A2 (Thompson, 1980 ; Van den Bosch, 1980 Bosch, , 1982 . Lysophosphatidylcholine is mainly metabolized by reacylation to phosphatidylcholine by acyltransferases (Lands, 1965;  Thompson, 1980) or further deacylation to glycerophosphocholine by lysophospholipases (Thompson, 1980 ; Van den Bosch, 1982) . This lyso lipid is an important intermediate in the remodelling of the fatty acyl moieties of phosphatidylcholine (Lands, 1965; Holub & Kuksis, 1978) , and has been suggested to play a role in the regulation of a number of membraneassociated enzymes (Weltzien, 1979) .
Lysophosphatidylcholine is the second most prevalent phospholipid in the plasma of rats and several other species (Nelson, 1967) , where it is associated with albumin (Switzer & Eder, 1965) . Lysophosphatidylcholine is readily taken up by tissues and can be used for the synthesis of phosphatidylcholine, or for the production of acetylcholine in nervous tissue (Stein & Stein, 1966; Illingworth & Portman, 1972; Portman & Illingworth, 1974; Savard & Choy, 1982; Ansell & Spanner, 1982b ; Esko & Matsuoka, 1983) . It has subsequently been reported that albumin enhances the release of lysophosphatidylcholine from isolated perfused rat liver (Sekas et al., 1985) and cultured rat hepatocytes (Mangiapane & Brindley, 1986; Graham et al., 1988a,b; Baisted et al., 1988) , which is most probably generated by hydrolysis of cellular phosphatidylcholine and is independent of lipoprotein secretion. This hepatic lysophosphatidylcholine is mainly unsaturated, unlike the highly saturated lysophosphatidylcholine formed by lecithincholesterol acyltransferase in plasma (Glomset, 1962; Sekas et al., 1985; Baisted et al., 1988) . T-he liver could be the major source of plasma lysophosphatidylcholine, since its concentration is relatively high in human patients with plasma lecithin-cholesterol acyltransferase deficiency (Norum & Gjone, 1967) . Graham et al. (1988a) have suggested that transport of lysophosphatidylcholine from the liver may be physiologically important in supplying extrahepatic tissues with essential fatty acids and choline.
In studies on choline-deficient hepatocytes, Yao & Vance (1988) reported that decreased secretion of triacylglycerol and phosphatidylcholine was due to impaired secretion of very-low-density lipoproteins, but not high-density lipoproteins. Addition of either choline or methionine rapidly corrected the defective very-lowdensity lipoprotein secretion from the choline-deficient cells. Synthesis of phosphatidylcholine is stimulated and the cellular phosphatidylcholine concentration is increased by the addition of choline or methionine, indicating that active synthesis of phosphatidylcholine via the CDP-choline pathway or by the rnethylation of B. S. Robinson and others phosphatidylethanolamine was required for very-lowdensity lipoprotein secretion.
We were curious whether or not the secretion of lysophosphatidylcholine would be perturbed in the choline-deficient cells, and whether or not phosphatidylcholine synthesis from exogenous lysophosphatidylcholine could overcome the impaired very-low-density lipoprotein secretion from these choline-deficient cells. Lysophosphatidylcholine metabolism in the cholinedeficient liver has not been previously studied.
EXPERIMENTAL Animals and diet
Male Sprague-Dawley rats (Rattus norvegicus), weighing 60-80 g, were housed in wire-mesh cages and given water and a choline-deficient diet (ICN Nutritional Biochemicals, Cleveland, OH, U.S.A.) ad libitum for 3 days before preparation of hepatocytes. The diet composition was (by wt.) 100 vitamin-free casein, 100 a-protein, 200% lard, 560% sucrose, 400 salt mixture (Wesson), and ICN vitamin fortification mixture except choline chloride.
Preparation and incubation of hepatocytes
Hepatocytes were isolated by a collagenase-perfusion technique essentially as described previously (Davis et al., 1979; Yao & Vance, 1988) . The isolated hepatocytes were resuspended in Dulbecco's modified Eagle's medium (choline-, methionine-and arginine-free) containing 17 0 (v/v) delipidated fetal-calf serum, 0.4mM-L-ornithine, 1.7 /tM-insulin, 100 units of penicillin G/ml, 100,tg of streptomycin sulphate/ml and 10 mM-Hepes, pH 7.4 (I x 106 cells/ml). The cells were dispensed into Primaria culture dishes (Falcon 3802, 60 mm x 15 mm; Becton Dickinson and Co., Oxnard, CA, U.S.A.) (3 ml/dish) and maintained in monolayer culture at 37°C under an atmosphere of air/CO2 (19: 1) for at least 6 h before all experiments.
The dishes of cultured hepatocytes were washed with 2 x 3 ml of serum-free medium (choline-, methionineand arginine-free modified Eagle's medium described above) to remove the delipidated serum and non-viable cells. The monolayer of hepatocytes was subsequently incubated with 2 ml of serum-free medium that contained radiolabelled and/or unlabelled metabolites as described in the legends to Figures Blue stain exclusion and constant cellular protein content indicated that hepatocytes were viable throughout the incubation, as observed previously (Yao & Vance, 1988) . The viability of the hepatocytes was also unaffected by exposure to 100 ,tM-lysophosphatidylcholine for up to 24 h. Extraction and analysis of lipids and water-soluble compounds from hepatocytes and culture medium
The lipids and water-soluble compounds were extracted and radioactivity was determined as previously described (Baisted et al., 1988) . The chemical amounts of lysophosphatidylcholine, phosphatidylcholine and triacylglycerol in the chloroform phase were determined as follows: a concentrated portion of the chloroform layer was applied to a silica-gel 60 t.l.c. plate along with 10 ,ug of each of lysophosphatidylcholine, phosphatidylcholine and triolein standards. The plate was developed half-way in the solvent system chloroform/methanol/ acetic acid/formic acid/water (35:15:6:2:1, by vol.) to separate phospholipids. The plate was dried and developed to the top in the solvent hexane/di-isopropyl ether/acetic acid (65:35:2, by vol.) to separate neutral lipids. The solvents contained the antioxidant 2,6-di-tbutyl-4-methylphenol (50 mg/l). The lysophosphatidylcholine, phosphatidylcholine and triacylglycerol areas were made visible with 12 vapour and scraped into 15 ml test tubes. Phospholipids were digested with HCl04 and the phosphorus content was measured (Rouser et al., 1966) . Triacylglycerol was treated with alkaline hydroxylamine and the content of fatty acyl groups determined (Snyder & Stephens, 1959 Tam et al. (1984) , and lysophosphatidyl[Me-3H]choline was purified by t.l.c. The lysophosphatidyl[Me-3H]choline was dissolved in water, and lysophosphatidylcholine (from egg yolk) was added to give a specific radioactivity of 250 d.p.m./nmol. All other chemicals were reagent grade. Choline-deficient rat hepatocytes, cultured for approx. 18 h in choline-, methionine-and arginine-free Dulbecco's modified Eagle's medium containing delipidated fetal-calf serum, were incubated for 2 h in 2 ml of serum-free medium containing 10 ,uCi of [Me-3H]choline. The prelabelled hepatocytes were subsequently incubated for up to 8 h in 2 ml of serum-free medium containing 28 /LM-choline without (C) or with (M) 5 mg of fatty acid-poor bovine serum albumin/ml. Media were collected at the times indicated, and the 3H associated with (a) total lipids, (b) lysophosphatidylcholine and (c) phosphatidylcholine was determined as described in the Experimental section. Each point represents the mean of two dishes, and the ranges were less than 5 % of the mean. This experiment was performed twice with similar results. (Fig. 1 a) . 1985; Mangiapane & Brindley, 1986; Graham et al., 1988a; Baisted et al., 1988) . The relatively high radioactivity associated with cellular phosphatidylcholine in the present study made it difficult to detect changes caused by albumin. Table 1 shows the effects of albumin and choline on the amounts of phosphatidylcholine and lysophosphatidylcholine produced by choline-deficient hepatocytes. When the hepatocytes were incubated with albumin for 4 h there was a small decrease in the amount of cellular phosphatidylcholine. There was no appreciable change in lysophosphatidylcholine mass in the cells. Albumin caused the amounts of phosphatidylcholine and lysophosphatidylcholine that were released into the medium to increase 1.4-and 74-fold respectively. The mass of lysophosphatidylcholine in the medium was higher than that of phosphatidylcholine after the incubation with albumin. As shown in Table 1 , there was a good correlation between loss of cellular phosphatidylcholine in the presence of albumin and an increase in the medium of phosphatidylcholine and lysophosphatidylcholine. Incubation of the choline-deficient hepatocytes with choline for 4 h increased the amount of phosphatidylcholine in the cells and medium (1.4-fold).
Addition of choline did not influence the amounts of lysophosphatidylcholine in cells and medium. When the choline-deficient hepatocytes were incubated with both choline and albumin there was less phosphatidylcholine in the cells and more phosphatidylcholine and lysophosphatidylcholine released into the medium than with choline alone. Again the presence of albumin caused the mass of lysophosphatidylcholine to be higher than that of phosphatidylcholine in the medium. The effects of albumin shown in Table 1 Lysophosphatidylcholine metabolism in choline-deficient hepatocytes [3H] phosphatidylcholine increased in the dense-protein, high-density-lipoprotein and low-densitylipoprotein fractions (4.4-, 1.4-and 1.6-fold respectively) and slightly decreased in the very-low-density-lipoprotein fraction with the addition of albumin. Table 2 indicates that albumin released lysophosphatidylcholine and phosphatidylcholine from the hepatocytes because of its ability to bind these phospholipids.
Previous work has provided evidence that the lysophosphatidylcholine released from cultured rat hepatocytes by albumin originates from the degradation of cellular phosphatidylcholine by phospholipases A1 and A2 and is not produced by the hydrolysis of phosphatidylcholine previously secreted (Sekas et al., 1985; Baisted et al., 1988; Graham et al., 1988b present results demonstrate that phosphatidylcholine is constantly being degraded in choline-deficient cultured rat hepatocytes to lysophosphatidylcholine which is released into the medium if albumin is present. In addition, the results show that albumin can directly release phosphatidylcholine from these cells. The synthesis of phosphatidylcholine via the CDP-choline pathway and methylation of phosphatidylethanolamine is restricted in choline-deficient hepatocyteg (Yao & Vance, 1988) , and most ofthe albumin-released lysophosphatidylcholine and phosphatidylcholine is probably derived from a pre-existing pool of cellular phosphatidylcholine. This hepatic phosphatidylcholine pool could be decreased if some of the lysophosphatidylcholine and phosphatidylcholine released into the medium in the presence of albumin were not transported back into the cells. Baisted et al. (1988) reported that glycerophosphocholine is directly secreted by cultured rat hepatocytes. It has been shown here that in the presence of albumin the secretion of glycerophosphocholine from cholinedeficient hepatocytes is decreased (Fig. 3) . A likely explanation for this phenomenon is that albumin removes lysophosphatidylcholine from the cells, leaving less precursors available for the formation ofglycerophosphocholine to be secreted. Since the levels oflysophosphatidylcholine were unchanged in albumin-treated cells (Table  1 ), the steady-state level of lysophosphatidylcholine is apparently unaffected.
The lysophosphatidylcholine and phosphatidylcholine released from choline-deficient hepatocytes by albumin is albumin-bound rather than associated with secreted lipoproteins. However, some of the lysophosphatidylcholine and phosphatidylcholine initially secreted with lipoproteins may later become associated with albumin in the medium. Davis et al. (1980) found that secretion of very-low-density lipoprotein by cultured rat hepatocytes is inhibited by high concentrations of albumin, owing to a viscosity effect. It is unlikely that this occurred in the present work, as a relatively low albumin concentration was used.
The release of lysophosphatidylcholine and phosphatidylcholine from the liver by albumin may provide a vital source of choline and fatty acids to the brain and other extrahepatic tissues during choline deficiency, when very-low-density lipoprotein secretion is suppressed. The intracellular location of the hepatic phosphatidylcholine pool from which the released lysophosphatidylcholine and phosphatidylcholine are derived and the phospholipases involved need to be determined. Effect of lysophosphatidylcholine on the synthesis of phosphatidylcholine and secretion of lipoproteins by choline-deficient cultured rat hepatocytes
The choline-deficient rat hepatocytes effectively utilized exogenous lysophosphatidylcholine to synthesize phosphatidylcholine. Fig. 4 indicates that the amount of cellular phosphatidylcholine increased approx. 1.4-fold after 4 h of lysophosphatidylcholine supplementation, and this concentration was maintained for up to 24 h. The stimulatory effect of lysophosphatidylcholine on the level of cellular phosphatidylcholine was identical with that of choline (Fig. 4) . Lysophosphatidyl cultured rat hepatocytes Choline-deficient rat hepatocytes were treated as described for Fig. 4 . Media were collected at the times indicated and the amounts of (a) triacylglycerol and (b) phosphatidylcholine (E, no addition; A, 100 tM-lysophosphatidylcholine; *, 100 pMcholine) determined as described in the Experimental section. Each point represents the mean of two dishes, and the ranges were less than 50O of the mean. Inset: hepatocytes were incubated with lysophosphatidyl[Me-3H]choline as for Fig. 4 inset. Media were collected at the times indicated and 3H associated with phosphatidylcholine was determined. Each point represents the mean of two dishes, and the ranges were less than 50O of the mean. The experiment was repeated twice with similar results.
1989 212 used as a tracer to determine the fate of the exogenous lysophosphatidylcholine. During the 24 h incubation period, less than 5 0 of the total radioactivity added was found in cellular and medium water-soluble compounds, indicating minimal degradation of the lysophosphatidylcholine. At least 95 00 of the total radioactivity incorporated in the hepatocytes was present in lipid compounds, of which about 9000, 400 and 400 was associated with phosphatidylcholine, lysophosphatidylcholine and sphingomyelin respectively. These results suggest that most of the supplemented lysophosphatidylcholine was transported as an intact molecule into the cells and rapidly acylated to form phosphatidylcholine.The synthesis of cellular [3H]phosphatidylcholine was almost constant with time during the first 12 h of incubation with [3H]lysophosphatidylcholine (Fig. 4,  inset) . When the choline-deficient hepatocytes were supplemented with lysophosphatidylcholine or choline, the mass secretion of triacylglycerol and phosphatidylcholine into the medium was stimulated 3-and 2-fold respectively (Figs. 5a and 5b ). An almost linear secretion of [3H]phosphatidylcholine was observed when the hepatocytes received [Me-3H]lysophosphatidylcholine as a tracer (Fig. Sb, inset) , indicating secretion of newly synthesized phosphatidylcholine made with the supplemented lysophosphatidylcholine.
To determine whether or not the stimulated secretion of triacylglycerol and phosphatidylcholine was a consequence of increased lipoprotein secretion, the culture medium was fractionated into very-low-density-lipoprotein, low-density-lipoprotein, high-density-lipoprotein and dense protein fractions and analysed. Highperformance t.l.c. of lipids in each of the four fractions showed that the increased secretion of triacylglycerol and phosphatidylcholine by the hepatocytes in the presence of lysophosphatidylcholine or choline was mainly due to stimulated very-low-density lipoprotein secretion. The stimulatory effect of lysophosphatidylcholine and choline on very-low-density-lipoprotein lipid secretion was almost identical. The secretion of lipids associated with other fractions was only slightly affected by the addition of lysophosphatidylcholine or choline. The secretion of [3H]leucine-labelled apolipoproteins in each of the four fractions was examined by SDS/polyacrylamide-gel electrophoresis followed by fluorography. The secretion of very-low-density-lipoprotein apolipoproteins (mainly apo BH, apo BL and apoE) was markedly stimulated by the addition of lysophosphatidylcholine or choline (Fig. 6) , further indicating enhanced release of apo B/ triacylglycerol-rich lipoproteins. The secretion of highdensity-lipoprotein apolipoproteins (mainly apo Al and apo E), albumin and other dense proteins by the hepatocytes was not changed by lysophosphatidylcholine or choline supplementation (Fig. 6) . . , x , , , . , > E s a : : -: : -. : f : : i : B : i : : 1 . i _ * x , * , ' : > : ; 1 . ; ; . ' . ; . z . e X . -; > . . lipoproteins secreted by choline-deficient cultured rat hepatocytes supplemented with lysophosphatidylcholine or choline Choline-deficient rat hepatocytes were cultured for approx. 5 h in choline-and methionine-free medium containing delipidated fetal-calf serum, and subsequently incubated for 12 h in 2 ml of serum-free medium containing 15 , uCi of L-[4,5-3H]leucine with no addition (-) , 100 /,M-choline (C) or 100 /tM-lysophosphatidylcholine (L). Media (combined from eight dishes) were collected and subjected to ultracentrifugation to fractionate lipoproteins. Lipoproteins in the dense-protein (BF), high-densitylipoprotein (HDL), low-density-lipoprotein (LDL) and very-low-density-lipoprotein (VLDL) fractions were concentrated by absorption on to Cab-O-Sil.
[3H]Apolipoproteins absorbed to the Cab-O-Sil were solubilized, and equal portions of the samples were subjected to SDS/polyacrylamide-gel electrophoresis and fluorography as described in the Experimental section. The X-ray film was exposed for 72 h for VLDL and 18 h for HDL and BF. There were no visible bands for LDL samples after exposure for 3 days. The positions of apolipoprotein standards are indicated on the left: Alb, albumin. This experiment was repeated twice with similar results. cellular uptake oflysophosphatidylcholine. The acylation of lysophosphatidylcholine to form phosphatidylcholine for lipoprotein secretion presumably occurs in the endoplasmic reticulum or Golgi membranes. It has recently been found that phosphatidylcholine synthesis is specifically required for normal hepatic very-low-density lipoprotein secretion, and cannot be replaced by the synthesis of phosphatidylethanolamine, phosphatidylmonomethylethanolamine or phosphatidyldimethylethanolamine (Z. Yao & D. E. Vance, unpublished work). The reason for this specific phospholipid requirement is unknown and warrants further investigation.
